Mcpherson's
- Short interest
- 0.30%
- +0.29 pp 30d
- as of 28 July 2026
- Reported shorts
- 429.2K
- Shares on issue
- 143.949M
Mcpherson's (MCP) financials
Results, ratios and statements
Latest result
Year to 30 Jun 2026 (FY26) vs FY25, figures in AUD, the reporting currency
- Revenue
- $118.3MM (source: ASX (Markit))vs $139.0M (FY25)
- ASX (Markit), as at 14 Oct 2026
- NPAT
- −$20.3MM (source: ASX (Markit))vs −$15.0M (FY25)
- ASX (Markit), as at 14 Oct 2026
- EPS (diluted)
- −$0.14vs −$0.10 (FY25)
- Yahoo Finance, as at 14 Oct 2026
- Rev YoY
- −14.9%FY
- EPS YoY
- n/aTTM
- ASX (Markit)
Summary of FY26 Appendix 4E, 27 Aug 2026
McPherson's full-year revenue fell 14.9% to $118.3m, with statutory net loss after tax widening 22% to $20.3m. No dividend was declared for FY26 due to retained losses. The company cited disruption from its new pharmacy wholesaler model and execution challenges, but expects the new operating model to provide a foundation for future growth.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 30 Jun 2026 (FY); no balance sheet aligned with this period; prices to 22 Oct 2026
- Gross margin
- 58.8%
- Operating margin
- −4.1%
- Net margin
- −17.1%
- FCF margin
- −0.5%
- ROE
- n/a
- ROA
- n/a
- FCF conversion
- n/a
- Net debt (excl. leases)
- n/a
- Net debt / EBITDA
- n/a
- Current ratio
- n/a
- Interest cover
- −10.6×
- Cash dividends paid / net profit
- n/a
- Market cap
- n/a (no share count we can vouch for)
- P/E
- n/a
- P/B
- n/a (no share count we can vouch for)
Ratios use the reporting currency (AUD); market cap is in AUD. Sources: Yahoo Finance, ASX (Markit) and Derived: trailing 12 months at year end, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY26 | FY25 | FY24 | FY23 |
|---|---|---|---|---|
| Revenue | $118.3MM (source: ASX (Markit)) | $139.0M | $144.6M | $210.3M |
| Gross profit | $69.6MT (source: Derived: trailing 12 months at year end) | $80.4M | $76.5M | $103.1M |
| Operating income | −$4.8MT (source: Derived: trailing 12 months at year end) | −$10.1M | −$8.2M | $8.5M |
| EBITDA | −$21.0MT (source: Derived: trailing 12 months at year end) | −$12.2M | −$4.9M | $3.1M |
| EBIT | −$25.2MT (source: Derived: trailing 12 months at year end) | −$18.7M | −$10.8M | −$2.9M |
| Interest expense | $458.0KT (source: Derived: trailing 12 months at year end) | $947.0K | $1.9M | $1.8M |
| Pretax income | −$25.7MT (source: Derived: trailing 12 months at year end) | −$19.7M | −$12.7M | −$4.7M |
| Tax | −$5.4MT (source: Derived: trailing 12 months at year end) | −$3.1M | −$1.4M | $389.0K |
| NPAT | −$20.3MM (source: ASX (Markit)) | −$15.0M | −$16.0M | −$5.1M |
| Net interest income | −$119.0KT (source: Derived: trailing 12 months at year end) | −$697.0K | −$1.8M | −$1.8M |
| EPS basic | −$0.14 | −$0.10 | −$0.11 | −$0.035 |
| EPS diluted | −$0.14 | −$0.10 | −$0.11 | −$0.035 |
| Shares | n/a | 143.9M | 143.9M | 143.9M |
- ASX (Markit)
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- FY26 Appendix 4EAnnual Results27 Aug 2026via asx_announcements
- 1H26 Financial Results PresentationFinancial Report25 Feb 2026via asx_announcements
- 1H26 Appendix 4D and Financial ReportHalf Year Results25 Feb 2026via asx_announcements
- 1H26 Financial ResultsFinancial Report25 Feb 2026via asx_announcements
- 2025 Annual ReportAnnual Report31 Dec 2025via crawler
- 2025 Annual General Meeting and Annual ReportAnnual Report29 Sep 2025via asx_announcements
- FY25 Appendix 4EAnnual Results27 Aug 2025via asx_announcements
- 1H25 Financial ResultsFinancial Report26 Feb 2025via asx_announcements
- 1H25 Appendix 4D and Financial ReportHalf Year Results26 Feb 2025via asx_announcements
- 1H25 Financial Results PresentationFinancial Report26 Feb 2025via asx_announcements
Showing 10 of 14 reports